Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome Patients

<p>Health Canada authorized the Company’s protocol amendment that expands eligibility to include patients aged 12 and older with stage four Rett syndrome in the REVEAL Phase 1/2 adult trial in Canada Protocol amendment broadens TSHA-102 treatment potential to both adolescent and adult patients with Rett syndrome Dosing of the third patient in the REVEAL Phase […]</p>
<p>The post <a href="https://forextv.com/top-news/taysha-gene-therapies-announces-expanded-eligibility-in-reveal-phase-1-2-adult-trial-to-include-adolescent-rett-syndrome-patients/">Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome Patients</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>